TY - JOUR
T1 - C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect
AU - Ratti, Antonia
AU - Corrado, Lucia
AU - Castellotti, Barbara
AU - Del Bo, Roberto
AU - Fogh, Isabella
AU - Cereda, Cristina
AU - Tiloca, Cinzia
AU - D'Ascenzo, Carla
AU - Bagarotti, Alessandra
AU - Pensato, Viviana
AU - Ranieri, Michela
AU - Gagliardi, Stella
AU - Calini, Daniela
AU - Mazzini, Letizia
AU - Taroni, Franco
AU - Corti, Stefania
AU - Ceroni, Mauro
AU - Oggioni, Gaia D.
AU - Lin, Kuang
AU - Powell, John F.
AU - Soraru, Gianni
AU - Ticozzi, Nicola
AU - Comi, Giacomo P.
AU - D'Alfonso, Sandra
AU - Gellera, Cinzia
AU - Silani, Vincenzo
AU - SLAGEN Consortium
PY - 2012/10
Y1 - 2012/10
N2 - A hexanucleotide repeat expansion (RE) in C9ORF72 gene was recently reported as the main cause of amyotrophic lateral sclerosis (ALS) and cases with frontotemporal dementia. We screened C9ORF72 in a large cohort of 259 familial ALS, 1275 sporadic ALS, and 862 control individuals of Italian descent. We found RE in 23.9% familial ALS, 5.1% sporadic ALS, and 0.2% controls. Two cases carried the RE together with mutations in other ALS-associated genes. The phenotype of RE carriers was characterized by bulbar-onset, shorter survival, and association with cognitive and behavioral impairment. Extrapyramidal and cerebellar signs were also observed in few patients. Genotype data revealed that 95% of RE carriers shared a restricted 10-single nucleotide polymorphism haplotype within the previously reported 20-single nucleotide polymorphism risk haplotype, detectable in only 27% of nonexpanded ALS cases and in 28% of controls, suggesting a common founder with cohorts of North European ancestry. Although C9ORF72 RE segregates with disease, the identification of RE both in controls and in patients carrying additional pathogenic mutations suggests that penetrance and phenotypic expression of C9ORF72 RE may depend on additional genetic risk factors. (C) 2012 Elsevier Inc. All rights reserved.
AB - A hexanucleotide repeat expansion (RE) in C9ORF72 gene was recently reported as the main cause of amyotrophic lateral sclerosis (ALS) and cases with frontotemporal dementia. We screened C9ORF72 in a large cohort of 259 familial ALS, 1275 sporadic ALS, and 862 control individuals of Italian descent. We found RE in 23.9% familial ALS, 5.1% sporadic ALS, and 0.2% controls. Two cases carried the RE together with mutations in other ALS-associated genes. The phenotype of RE carriers was characterized by bulbar-onset, shorter survival, and association with cognitive and behavioral impairment. Extrapyramidal and cerebellar signs were also observed in few patients. Genotype data revealed that 95% of RE carriers shared a restricted 10-single nucleotide polymorphism haplotype within the previously reported 20-single nucleotide polymorphism risk haplotype, detectable in only 27% of nonexpanded ALS cases and in 28% of controls, suggesting a common founder with cohorts of North European ancestry. Although C9ORF72 RE segregates with disease, the identification of RE both in controls and in patients carrying additional pathogenic mutations suggests that penetrance and phenotypic expression of C9ORF72 RE may depend on additional genetic risk factors. (C) 2012 Elsevier Inc. All rights reserved.
U2 - 10.1016/j.neurobiolaging.2012.06.008
DO - 10.1016/j.neurobiolaging.2012.06.008
M3 - Article
SN - 0197-4580
VL - 33
SP - -
JO - Neurobiology of Aging
JF - Neurobiology of Aging
IS - 10
M1 - 2528.e7
ER -